Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ago 178
2. Ago-178
3. Ago178
4. N-(2-(7-methoxy-1-naphthyl)ethyl)acetamide
5. S 20098
6. S-20098
7. S20098
8. Thymanax
9. Valdoxan
1. 138112-76-2
2. Thymanax
3. Valdoxan
4. N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide
5. N-(2-(7-methoxynaphthalen-1-yl)ethyl)acetamide
6. S20098
7. S-20098
8. Agomelatine [inn]
9. Melitor
10. Ago-178
11. S 20098
12. Acetamide, N-[2-(7-methoxy-1-naphthalenyl)ethyl]-
13. N-(2-(7-methoxy-1-naphthyl)ethyl)acetamide
14. N-(2-(7-methoxynaphth-1-yl)ethyl)acetamide
15. N-(2-(7-methoxy-1-naphthalenyl)ethyl)acetamide
16. Chembl10878
17. 137r1n49ad
18. N-[2-(7-methoxy-1-naphthalenyl)ethyl]acetamide
19. Agomelatine (inn)
20. Ncgc00253646-01
21. N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide
22. Acetamide, N-(2-(7-methoxy-1-naphthalenyl)ethyl)-
23. N-[2-(7-methoxy-naphthalen-1-yl)-ethyl]-acetamide
24. Ago 178
25. Valdoxan (tn)
26. Unii-137r1n49ad
27. Ago178
28. N-[2-(7-methoxynaphth-1-yl)ethyl]acetamide
29. Sr-01000944938
30. Agomelatine [inn:ban]
31. Ago178c
32. Agomelatine-[d4]
33. Awy
34. Agomelatine- Bio-x
35. Mfcd00916659
36. Agomelatine [mi]
37. Agomelatine [mart.]
38. Dsstox_cid_31431
39. Dsstox_rid_97317
40. Dsstox_gsid_57642
41. Agomelatine [who-dd]
42. Gtpl198
43. Mls006011913
44. Schembl114476
45. Agomelatine [ema Epar]
46. Zinc5608
47. Dtxsid3057642
48. Agomelatine, >=98% (hplc)
49. Chebi:134990
50. Bcpp000421
51. Hms3604n09
52. Hms3648g18
53. Hms3654b07
54. Hms3884a07
55. Bcp02084
56. Tox21_113772
57. Bbl029084
58. Bdbm50035179
59. Pdsp1_001305
60. Pdsp1_001784
61. Pdsp2_001289
62. Pdsp2_001767
63. S1243
64. Stl237728
65. Akos005145681
66. Ac-3395
67. Bcp9000250
68. Ccg-221950
69. Cs-0740
70. Db06594
71. Ks-1247
72. Sb19508
73. Ncgc00253646-10
74. Ba167079
75. Hy-17038
76. Smr002530056
77. Am20090763
78. B2262
79. Cas-138112-76-2
80. Ft-0657383
81. Sw219177-1
82. A19445
83. D02578
84. Ab01274769-01
85. Ab01274769_02
86. 112a762
87. L000528
88. Q395229
89. Q-102507
90. Sr-01000944938-1
91. Sr-01000944938-3
92. F0001-2383
93. (4-chlorophenyl)-[(9h-fluoren-9-ylmethoxycarbonylamino)]-aceticacid
94. N-[2-(7-methoxy-naphthalen-1-yl)-ethyl]-acetamide(agomelatine)
Molecular Weight | 243.30 g/mol |
---|---|
Molecular Formula | C15H17NO2 |
XLogP3 | 2.7 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 4 |
Exact Mass | 243.125928785 g/mol |
Monoisotopic Mass | 243.125928785 g/mol |
Topological Polar Surface Area | 38.3 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 280 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Agomelatine is indicated to treat major depressive episodes in adults.
Treatment of major depressive episodes in adults.
Treatment of major depressive episodes in adults.
Treatment of major depressive episodes
Agomelatine resynchronises circadian rhythms in animal models of delayed sleep phase syndrome and other circadian rhythm disruptions. It increases noradrenaline and dopamine release specifically in the frontal cortex and has no influence on the extracellular levels of serotonin. Agomelatine has shown an antidepressant-like effect in animal depression models, (learned helplessness test, despair test, and chronic mild stress) circadian rhythm desynchronisation, and in stress and anxiety models. In humans, agomelatine has positive phase shifting properties; it induces a phase advance of sleep, body temperature decline and melatonin onset. Controlled studies in humans have shown that agomelatine is as effective as the SSRI antidepressants paroxetine and sertraline in the treatment of major depression
Hypnotics and Sedatives
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)
N06AX22
N06AX22
N06AX22
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
N - Nervous system
N06 - Psychoanaleptics
N06A - Antidepressants
N06AX - Other antidepressants
N06AX22 - Agomelatine
Absorption
Bioavailability is less than 5%.
Hepatic (90% CYP1A2 and 10% CYP2C9).
<2 hours
The novel antidepressant agent, agomelatine, behaves as an agonist at melatonin receptors (MT1 and MT2) and as an antagonist at serotonin (5-HT)(2C) receptors.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26965
Submission : 2013-03-08
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38958
Submission : 2023-09-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27206
Submission : 2013-06-21
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Agomelatine Phosphoric Acid IH
Date of Issue : 2022-06-17
Valid Till : 2025-07-07
Written Confirmation Number : WC-0067
Address of the Firm : Chemical Technical Operations Unit-VI, APIIC Industrial Estate, Pydibhimavaram V...
Date of Issue : 2022-06-17
Valid Till : 2025-07-02
Written Confirmation Number : WC-0082
Address of the Firm : API Division Kharakhadi, Plot No. 842-843, Kharakhadi, Padra Vadodara-391 450, G...
Date of Issue : 2019-10-22
Valid Till : 2022-07-02
Written Confirmation Number : WC-0082A5
Address of the Firm : API Division Kharakhadi, Plot No. 842-843, Kharakhadi, Padra Vadodara-391 450, G...
Date of Issue : 2020-02-14
Valid Till : 2022-07-02
Written Confirmation Number : WC-0214
Address of the Firm : Gut No. 546, 571, 519 & 520, Village: Kumbhavali, Tarapur, Boisar, Tal & DIst- P...
Date of Issue : 2019-08-16
Valid Till : 2025-08-15
Written Confirmation Number : WC-0022
Address of the Firm : Plot No. 212, A, B, C, D, IDA, Phase II, Pashamylaram (V), Patancheru (M), Sanga...
Date of Issue : 2020-07-23
Valid Till : 2023-05-11
Written Confirmation Number : WC-0273
Address of the Firm : Plot No. 34A, J.N.Pharma City, Thanam (V), Parawada (M), Vishakhapatnam-District...
Date of Issue : 2019-10-07
Valid Till : 2022-09-08
Written Confirmation Number : WC-0072
Address of the Firm : Plot No. 25/B, Phase-III, I.D.A., Jeedimetla, Hyderabad-500 055. AP.
Agomelatine citric acid co-crystal lH
Date of Issue : 2022-07-27
Valid Till : 2023-10-14
Written Confirmation Number : WC-0133A3
Address of the Firm : Plot No 3501 to 3515, 6301 to 6313 & 16 Meter Road/C\\r\\nG.I.D.C Estate, Ankles...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Agomelatin Zentiva
Dosage Form : Filmtabl
Dosage Strength : 25mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Agomelatin Zentiva
Dosage Form : Filmtabl
Dosage Strength : 25mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info : Dossier Availability- Q1 2017
Registration Country : Austria
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q1 2017
Registration Country : Austria
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : FC Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info :
Registration Country : Sweden
Brand Name : Valdoxan
Dosage Form : FILM COATED PILL
Dosage Strength : 25 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Switzerland
Brand Name : Agomelatin-Mepha
Dosage Form : Filmtabl
Dosage Strength : 25mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Agomelatine Servier
Dosage Form : Film-Coated Tablets
Dosage Strength : 25mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Valdoxan
Dosage Form : Filmtabl
Dosage Strength : 25mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Valdoxan
Dosage Form : Filmtabl
Dosage Strength : 25mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Agomelatin Zentiva
Dosage Form : Filmtabl
Dosage Strength : 25mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Agomelatin Zentiva
Dosage Form : Filmtabl
Dosage Strength : 25mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Sweden
Brand Name : Valdoxan
Dosage Form : FILM COATED PILL
Dosage Strength : 25 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Valdoxan
Dosage Form : Antic-calc Tablet, Film Coated
Dosage Strength : 25 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Switzerland
Brand Name : Agomelatine Servier
Dosage Form : Film-Coated Tablets
Dosage Strength : 25mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Agomelatine Servier
Dosage Form : Film-Coated Tablets
Dosage Strength : 25mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Agomelatin Spirig HC
Dosage Form : Filmtabl
Dosage Strength : 25mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Agomelatin Spirig HC
Dosage Form : Filmtabl
Dosage Strength : 25mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info : Generic
Registration Country : Turkey
Brand Name :
Dosage Form : FILM COATED TABLET
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey
Regulatory Info :
Registration Country : Sweden
Brand Name : Thymanax
Dosage Form : FILM COATED PILL
Dosage Strength : 25 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Dossier Availability- Q1 2017
Registration Country : Austria
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q1 2017
Registration Country : Austria
Packaging :
Regulatory Info : Dossier Availability- Q1 2017
Dosage : Film Coated Tablet
Dosage Strength : 25MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Austria
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Packaging :
Regulatory Info : Dossier Availability- Q2 2017
Dosage : Film Coated Tablet
Dosage Strength : 50MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Austria
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability- Q2 2017
Registration Country : Austria
Packaging :
Regulatory Info : Dossier Availability- Q2 2017
Dosage : Film Coated Tablet
Dosage Strength : 30MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Austria
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : FC Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : FC Tablet
Dosage Strength : 25MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : Tablet
Dosage Strength : 25MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : South Korea
Brand Name : Argotin
Dosage Form : Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 25MG
Brand Name : Argotin
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info :
Registration Country : Turkey
Brand Name : AGOMELT
Dosage Form : FILM COATED TABLET
Dosage Strength : 25MG
Packaging : 28 TABLETS
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging : 28 TABLETS
Regulatory Info :
Dosage : FILM COATED TABLET
Dosage Strength : 25MG
Brand Name : AGOMELT
Approval Date :
Application Number :
Registration Country : Turkey
Global Sales Information
Market Place
Reply
16 Aug 2021
Reply
08 Feb 2019
Reply
19 Sep 2018
Reply
25 Oct 2017
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?